U.S. Specialized REITs Stock News

What the latest CSW Industrials earnings mean for investors CSW Industrials (CSW) just reported its fiscal 2027 first quarter results, with sales of US$350.65 million and net income of US$49.76 million. Management paired the update with a clear push toward future acquisitions. See our latest analysis for CSW Industrials. CSW Industrials' recent earnings update and acquisition focus come after a strong run in the stock, with a 26.51% 1 month share price return and a 39.50% 1 year total...

SpaceX’s first public earnings report is about to put fresh pressure on satellite and launch stocks, especially with the lockup expiry set to release up to 20% of its shares into the market. With investors watching Starlink, Starship and rising capital expenditure plans, the risk and reward profile around competitors is changing fast. This article looks at how that news could weigh on three stocks, all potentially facing tougher competition, heavier pricing pressure or higher execution risk...

Leonardo DRS (DRS) is in focus after reporting second quarter 2026 results, highlighting higher sales, improved profitability and reaffirmed full year revenue guidance, along with a quarterly dividend and progress on its share repurchase program. See our latest analysis for Leonardo DRS. Despite the earnings beat, dividend declaration and active buyback, Leonardo DRS shares have eased over 1-day and 7-day periods. However, the year-to-date share price return of 30.16% and 3-year total...

Coinbase Global (COIN) is back in focus after second quarter 2026 results showed lower revenue and a return to losses, while debate over the CLARITY Act and fresh buying from Cathie Wood keep attention on the stock. See our latest analysis for Coinbase Global. At a share price of $150.73, Coinbase Global has seen sharp swings, with a 1 day share price return of 2.89% following Q2 results, but a 90 day share price return down 23.86%. Over a longer horizon, total shareholder return is down...

Federal National Mortgage Association (FNMA) reported second quarter 2026 net income of US$3,982m and first half net income of US$7,702m, compared with US$3,317m and US$6,978m in the prior periods. See our latest analysis for Federal National Mortgage Association. Despite the stronger second quarter, Federal National Mortgage Association's share price has fallen 31% over the past three months and is down 48% year to date, although the five year total shareholder return is still a multiple of...

In the past quarter, Stewart Information Services Corporation reported second-quarter 2026 revenue of US$899.24 million, up from US$722.18 million a year earlier, with net income rising to US$37.22 million and diluted EPS from continuing operations increasing to US$1.21. For the first half of 2026, the company’s revenue grew to US$1.68 billion and net income to US$54.18 million, suggesting improving profitability and operating leverage across its core title and real estate services...

Energizer Holdings, Inc. has reported its third-quarter 2026 results, with sales rising slightly to US$734.1 million while net income fell sharply to US$39.9 million compared with the same period last year. Despite this steep earnings drop over both the quarter and the nine-month period, the Board still declared a US$0.30 per share dividend payable in September 2026. Next, we'll look at what the sharp earnings decline alongside steady sales means for Energizer Holdings' broader investment...

LeMaitre Vascular (NASDAQ: LMAT) recently reported quarterly results following its scheduled earnings announcement, after analysts had projected 11.5% year-on-year revenue growth, slower than the prior year’s increase and against a mixed history of meeting estimates. This shift in expected growth, combined with the company’s uneven record versus analyst forecasts over the last two years, has sharpened attention on how reliably LeMaitre can convert its market opportunities into consistent...

Lexicon Pharmaceuticals recently reported completion of patient randomization in its pivotal Phase 3 SONATA-HCM trial of sotagliflozin for both obstructive and non-obstructive hypertrophic cardiomyopathy, after enrolling more than 500 patients across over 130 sites in 20 countries. The study’s focus on a large, predominantly non-obstructive HCM population, where treatment options remain limited, positions SONATA-HCM as the largest and only ongoing Phase 3 trial simultaneously covering both...

Kymera Therapeutics recently appointed Terence Rooney, MD, a seasoned immunology drug development leader from Johnson & Johnson, Eli Lilly, and Roche, as Chief Medical Officer, succeeding Jared Gollob, MD, who will retire and remain an advisor through year-end. Rooney’s broad experience shepherding multiple immunology therapies from early trials to commercialization, across modalities and disease areas, could materially influence how Kymera advances its oral immunology portfolio. We’ll now...

Knife River Corporation recently reported past second-quarter 2026 results showing revenue rising to US$938.6 million from US$833.8 million, while net income eased to US$43.9 million from US$50.6 million and earnings per share slipped to US$0.77 from US$0.89. Alongside higher six-month revenues and a wider half-year net loss, Knife River introduced full-year 2026 revenue guidance of US$3.40–US$3.60 billion, giving investors a clearer view of expected scale despite near-term profit...

Freshworks (FRSH) is drawing attention as investors weigh a new leadership chapter alongside its upcoming earnings report, following the appointment of Ryan Manning as Chief Product and Technology Officer. See our latest analysis for Freshworks. Freshworks’ recent leadership change and the upcoming earnings update come on the back of firm short term share price momentum, with a 30 day share price return of 13.83% and a 90 day share price return of 32.40%, even as the 1 year total shareholder...

Palantir’s strong Q2 report, with higher than expected earnings, revenue and large contract wins, has pushed enterprise AI back into the spotlight. When a key player shows this kind of momentum, it can sharpen competition for every stock tied to AI platforms, data analytics and government or commercial AI contracts. Some companies may benefit from renewed attention and budgets, while others risk losing deals or pricing power. This article focuses on the potential downside. You will see 3...

Chefs' Warehouse (CHEF) is back on investors' radar after issuing full year 2026 net sales guidance of US$4.50b to US$4.60b, alongside its latest quarterly earnings release. See our latest analysis for Chefs' Warehouse. The earnings release and 2026 sales guidance have come on the back of strong momentum in Chefs' Warehouse, with the stock delivering a 16.4% 1 month share price return and a 282.47% 3 year total shareholder return, even after a 3.51% 1 day pullback. If this kind of move has...

Crocs, Inc. recently reported second-quarter 2026 results showing revenue of US$1,179.47 million and a swing to net income of US$204.89 million, and it raised full-year 2026 guidance to anticipate roughly flat third-quarter revenue and GAAP diluted EPS of US$12.47 to US$12.77. The company also expanded its share repurchase authorization to US$5.21 billion and has already retired 58,676,968 shares over time, signaling a continued focus on returning cash to shareholders alongside improving...

Genius Sports recently announced a partnership with Polymarket, granting exclusive streaming rights, league IP, official data and integrity services for selected competitions on Polymarket’s CFTC-regulated U.S. prediction-market platform. The deal makes Polymarket an early mover in pairing live sports streams such as Serie A with real-time, regulated event contracts, while deepening Genius Sports’ role in data monetization, integrity monitoring and digital marketing across a growing roster...

Grand Canyon Education (LOPE) is back in focus after Q2 2026 earnings and fresh guidance, as investors weigh higher service revenue, updated terms with Grand Canyon University, and long term growth projects in new academic programs. See our latest analysis for Grand Canyon Education. At a share price of $150.80, Grand Canyon Education has seen its 90 day share price return fall 8.33%, while the 3 year total shareholder return of 36.98% and 5 year total shareholder return of 68.64% point to...

Tariffs are back in the headlines, with new Section 301 duties facing a court challenge from 25 states and fresh uncertainty for companies that rely on global supply chains. For US investors, that puts extra focus on large manufacturers with strong balance sheets and a clear domestic footprint, since some of these businesses could see relative advantages if imported rivals face higher or less predictable costs. This article looks at three US domestic manufacturing stocks from our screener...

KLA stock has delivered a very large 462.1% return over the past five years, yet its current checks lean expensive rather than cheap. After such a strong run and with recent weakness in the share price, investors are asking whether the current valuation still leaves enough room for future returns to justify the risk. The five year return of 462.1% shows how powerfully KLA has rewarded long term shareholders, which raises the bar for what the current price needs to justify. Recent enthusiasm...

SoundHound AI stock has delivered a very strong 206.5% gain over the past three years, yet the current valuation checks suggest the shares are pricing in a lot of optimism rather than offering a clear bargain. Over three years, SoundHound AI has returned 206.5%, which puts extra focus on whether that earlier strength still lines up with today’s fundamentals. Partnerships such as the MUSC Health and Deliverect collaborations can support longer term growth expectations, while the LivePerson...

Strong earnings from AI and industrial leaders, a drop in oil prices, and solid S&P 500 profit growth are giving U.S. mega-cap blue chips fresh attention. For long term investors, this mix of robust corporate results and easing cost pressures can reshape how large, established stocks are priced and perceived. The U.S. Mega-Cap Blue Chip Stocks screener focuses on financially healthy giants with sizeable market caps, value support, dividends, and moderate risk profiles. This article walks...

Humana Inc. has already reported second-quarter 2026 results, with revenue of US$40,867 million and net income of US$694 million, while also lowering its full-year 2026 GAAP EPS guidance to at least US$6.52 from at least US$8.36. Alongside these results, Humana completed a US$276.13 million share repurchase program and added two experienced executives, Paul Smith and Frederick Crawford, to its Board, potentially influencing future governance and capital allocation decisions. With Humana...

Albemarle board change and analyst expectations set the stage Albemarle (ALB) has drawn fresh attention after appointing former Vale chief executive Eduardo Bartolomeo to its Board, while Wall Street analysts outline expectations for higher earnings, revenue and Energy Storage segment contribution. See our latest analysis for Albemarle. Albemarle's share price has moved sharply over different timeframes, with the stock up 4.9% over the past week but down 38.4% over three months. A 1 year...

Adaptive Biotechnologies stock has delivered a very strong 247.5% return over the past three years, yet current checks suggest it no longer looks obviously cheap, with the intrinsic value estimate sitting close to the share price while traditional multiples point to a premium. Over the last three years, investors in Adaptive Biotechnologies have seen a 247.5% return, which puts more pressure on today’s buyers to justify the current price. The recent focus on the Minimal Residual Disease...